I suspect you are right Killer Whale. The DEA has a number of options here, and rescheduling CBD to a higher level that would allow doctors to prescribe CBD for medical treatment is only one of them. In my opinion, THC will be recommended for additional study, and the same could be true of CBD. Although reclassification for CBD is likely, the DEA has discretion in regard to how far they might go. They could remove CBD from the Controlled Substances list altogether, or move CBD to level four or five. Level four or five means there is anecdotal evidence of medical merit, while removal from the Controlled Substances Act will in effect make CBD legal and available to all (I must tell you this is still not a straight line procedure). No matter what happens, the DEA must make a decision, and they must follow the recommendation of the FDA. The discretion of the DEA is only a matter of degree. Furthermore, I predict this is only one step along the road to eventual legality. CBD has so very much going for it, and supporter are growing every single day.
With luck, I might have more to tell you tomorrow.
News 
Market Data 
Discover 
AI
